Pharmacogenomics of neurodegenerative diseases: Roles in personalized medicines

Ruby E. Evande, Rinku Dutta, Chalet Tan, Jean L Grem, Ram I Mahato

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pharmacogenomics is the study of the role of genetic variations in drug response. In the study of pharmacogenomics, one can relate variations in drug exposure and/or drug response (pharmacology) to the variations in genes (genomics). An administered drug may fail to work for one patient, but show the expected result for another. In some cases a drug may work well for a larger group of patients, while causing a subset of patients to experience unexpected or severe side effects. These adverse drug reactions can be harmful and sometimes deadly. Factors such as the environment, diet, age, lifestyle and co-morbid conditions all may influence the individual’s response to drugs. Each is covered in this chapter with an eye towards how best to administer drug to individual patients.

Original languageEnglish (US)
Title of host publicationNeuroimmune Pharmacology
PublisherSpringer International Publishing
Pages959-970
Number of pages12
ISBN (Electronic)9783319440224
ISBN (Print)9783319440200
DOIs
StatePublished - Jan 1 2016

Fingerprint

Precision Medicine
Pharmacogenetics
Neurodegenerative Diseases
Pharmaceutical Preparations
Genomics
Drug-Related Side Effects and Adverse Reactions
Life Style
Pharmacology
Diet
Genes

Keywords

  • Gene variants
  • Metabolizers
  • Neurodegenerative
  • Pharmacogenomics

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Evande, R. E., Dutta, R., Tan, C., Grem, J. L., & Mahato, R. I. (2016). Pharmacogenomics of neurodegenerative diseases: Roles in personalized medicines. In Neuroimmune Pharmacology (pp. 959-970). Springer International Publishing. https://doi.org/10.1007/978-3-319-44022-4_55

Pharmacogenomics of neurodegenerative diseases : Roles in personalized medicines. / Evande, Ruby E.; Dutta, Rinku; Tan, Chalet; Grem, Jean L; Mahato, Ram I.

Neuroimmune Pharmacology. Springer International Publishing, 2016. p. 959-970.

Research output: Chapter in Book/Report/Conference proceedingChapter

Evande, RE, Dutta, R, Tan, C, Grem, JL & Mahato, RI 2016, Pharmacogenomics of neurodegenerative diseases: Roles in personalized medicines. in Neuroimmune Pharmacology. Springer International Publishing, pp. 959-970. https://doi.org/10.1007/978-3-319-44022-4_55
Evande RE, Dutta R, Tan C, Grem JL, Mahato RI. Pharmacogenomics of neurodegenerative diseases: Roles in personalized medicines. In Neuroimmune Pharmacology. Springer International Publishing. 2016. p. 959-970 https://doi.org/10.1007/978-3-319-44022-4_55
Evande, Ruby E. ; Dutta, Rinku ; Tan, Chalet ; Grem, Jean L ; Mahato, Ram I. / Pharmacogenomics of neurodegenerative diseases : Roles in personalized medicines. Neuroimmune Pharmacology. Springer International Publishing, 2016. pp. 959-970
@inbook{8107068c6f5f4203a36ade2ef2289c27,
title = "Pharmacogenomics of neurodegenerative diseases: Roles in personalized medicines",
abstract = "Pharmacogenomics is the study of the role of genetic variations in drug response. In the study of pharmacogenomics, one can relate variations in drug exposure and/or drug response (pharmacology) to the variations in genes (genomics). An administered drug may fail to work for one patient, but show the expected result for another. In some cases a drug may work well for a larger group of patients, while causing a subset of patients to experience unexpected or severe side effects. These adverse drug reactions can be harmful and sometimes deadly. Factors such as the environment, diet, age, lifestyle and co-morbid conditions all may influence the individual’s response to drugs. Each is covered in this chapter with an eye towards how best to administer drug to individual patients.",
keywords = "Gene variants, Metabolizers, Neurodegenerative, Pharmacogenomics",
author = "Evande, {Ruby E.} and Rinku Dutta and Chalet Tan and Grem, {Jean L} and Mahato, {Ram I}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-44022-4_55",
language = "English (US)",
isbn = "9783319440200",
pages = "959--970",
booktitle = "Neuroimmune Pharmacology",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Pharmacogenomics of neurodegenerative diseases

T2 - Roles in personalized medicines

AU - Evande, Ruby E.

AU - Dutta, Rinku

AU - Tan, Chalet

AU - Grem, Jean L

AU - Mahato, Ram I

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Pharmacogenomics is the study of the role of genetic variations in drug response. In the study of pharmacogenomics, one can relate variations in drug exposure and/or drug response (pharmacology) to the variations in genes (genomics). An administered drug may fail to work for one patient, but show the expected result for another. In some cases a drug may work well for a larger group of patients, while causing a subset of patients to experience unexpected or severe side effects. These adverse drug reactions can be harmful and sometimes deadly. Factors such as the environment, diet, age, lifestyle and co-morbid conditions all may influence the individual’s response to drugs. Each is covered in this chapter with an eye towards how best to administer drug to individual patients.

AB - Pharmacogenomics is the study of the role of genetic variations in drug response. In the study of pharmacogenomics, one can relate variations in drug exposure and/or drug response (pharmacology) to the variations in genes (genomics). An administered drug may fail to work for one patient, but show the expected result for another. In some cases a drug may work well for a larger group of patients, while causing a subset of patients to experience unexpected or severe side effects. These adverse drug reactions can be harmful and sometimes deadly. Factors such as the environment, diet, age, lifestyle and co-morbid conditions all may influence the individual’s response to drugs. Each is covered in this chapter with an eye towards how best to administer drug to individual patients.

KW - Gene variants

KW - Metabolizers

KW - Neurodegenerative

KW - Pharmacogenomics

UR - http://www.scopus.com/inward/record.url?scp=85045981300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045981300&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-44022-4_55

DO - 10.1007/978-3-319-44022-4_55

M3 - Chapter

AN - SCOPUS:85045981300

SN - 9783319440200

SP - 959

EP - 970

BT - Neuroimmune Pharmacology

PB - Springer International Publishing

ER -